InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Hagen Heidi, Director. Insider active across 2 companies, notably Vericel Corp. Cumulatively, 10 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €35k. Activity tracked since 19 May 2021. The latest transaction was filed on 23 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hagen Heidi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
3,200 sharesCommon StockSEC:0001140361-26-018543:0
15,000 shares@ US$2.7640.1% of flowCommon StockSEC:0001140361-26-011091:0
3,200 sharesCommon StockSEC:0001140361-25-017118:0
9,000 shares@ US$3.7453.1% of flowCommon StockSEC:0001140361-25-007181:0
4,000 shares@ US$3.7422.7% of flowCommon StockSEC:0001140361-24-043798:0
3,200 sharesCommon StockSEC:0001140361-24-024331:0
2,600 sharesCommon StockSEC:0001140361-23-021498:0
2,600 sharesCommon StockSEC:0001593968-22-000888:0
23,770 shares@ US$1.76100.0% of flowCommon StockSEC:0001209191-21-054829:0
Canonical exit: 1 Dec 2021 (T+90)
1,500 shares@ US$6.008.3% of flowCommon StockSEC:0001593968-21-001389:0
10 of 10 declarations
About Hagen Heidi
Heidi Hagen is a Board Member at Vericel Corp and ZIOPHARM ONCOLOGY INC. She plays an important role in the governance of these companies, bringing her expertise in strategy and management. As a board member, she participates in strategic decision-making and guides the companies toward a sustainable future.
